Weekly Investment Analysts’ Ratings Changes for GE HealthCare Technologies (GEHC)

GE HealthCare Technologies (NASDAQ: GEHC) recently received a number of ratings updates from brokerages and research firms:

• 7/17/2026 – GE HealthCare Technologies is now covered by Hovde Group. They set a “market perform” rating and a $14.00 price target on the stock.
• 7/16/2026 – GE HealthCare Technologies had its price target lowered by UBS Group AG from $69.00 to $67.00. They now have a “neutral” rating on the stock.
• 7/13/2026 – GE HealthCare Technologies had its “buy” rating reaffirmed by BTIG Research. They now have a $75.00 price target on the stock.
• 7/8/2026 – GE HealthCare Technologies is now covered by BMO Capital Markets. They set a “market perform” rating and a $70.00 price target on the stock.
• 7/8/2026 – GE HealthCare Technologies had its “neutral” rating reaffirmed by Citigroup Inc..
• 7/8/2026 – GE HealthCare Technologies was upgraded by BMO Capital Markets to “hold”.
• 6/23/2026 – GE HealthCare Technologies is now covered by Royal Bank Of Canada. They set an “outperform” rating and a $80.00 price target on the stock.
• 6/23/2026 – GE HealthCare Technologies is now covered by Royal Bank Of Canada. They set an “outperform” rating and a $80.00 price target on the stock.
• 6/8/2026 – GE HealthCare Technologies had its “neutral” rating reaffirmed by The Goldman Sachs Group, Inc..

GE HealthCare Technologies Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, August 14th. Shareholders of record on Friday, July 24th will be given a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date of this dividend is Friday, July 24th. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 3.35%.

Insiders Place Their Bets

In other news, Director Watkin Phoebe L. Yang acquired 1,000 shares of the firm’s stock in a transaction that occurred on Friday, May 8th. The stock was bought at an average price of $63.01 per share, with a total value of $63,010.00. Following the acquisition, the director owned 13,702 shares in the company, valued at $863,363.02. The trade was a 7.87% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Rodney F. Hochman acquired 1,618 shares of the stock in a transaction that occurred on Tuesday, May 12th. The stock was purchased at an average price of $62.03 per share, for a total transaction of $100,364.54. Following the completion of the purchase, the director directly owned 1,618 shares in the company, valued at $100,364.54. This trade represents a ∞ increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Over the last ninety days, insiders bought 21,847 shares of company stock valued at $1,361,355. Company insiders own 0.36% of the company’s stock.

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.